Title: Scriptaid effects on breast cancer cell lines.
Journal: Journal of cellular physiology 20121001
Title: Histone deacetylase inhibition improves activation of ribosomal RNA genes and embryonic nucleolar reprogramming in cloned mouse embryos.
Journal: Biology of reproduction 20111101
Title: AMP-activated protein kinase regulates beta-catenin transcription via histone deacetylase 5.
Journal: The Journal of biological chemistry 20110506
Title: Enrichment of Nur77 mediated by retinoic acid receptor β leads to apoptosis of human hepatocellular carcinoma cells induced by fenretinide and histone deacetylase inhibitors.
Journal: Hepatology (Baltimore, Md.) 20110301
Title: Treatment with a histone deacetylase inhibitor after nuclear transfer improves the preimplantation development of cloned bovine embryos.
Journal: The Journal of reproduction and development 20110201
Title: Identification of fetal hemoglobin-inducing agents using the human leukemia KU812 cell line.
Journal: Experimental biology and medicine (Maywood, N.J.) 20101101
Title: HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity.
Journal: Journal of cellular and molecular medicine 20100801
Title: Histone deacetylase inhibitor Scriptaid reactivates latent HIV-1 promoter by inducing histone modification in in vitro latency cell lines.
Journal: International journal of molecular medicine 20100801
Title: Histone deacetylase inhibitors de-repress tyrosine hydroxylase expression in the olfactory bulb and rostral migratory stream.
Journal: Biochemical and biophysical research communications 20100319
Title: Chemical phylogenetics of histone deacetylases.
Journal: Nature chemical biology 20100301
Title: Histone deacetylase inhibitors improve in vitro and in vivo developmental competence of somatic cell nuclear transfer porcine embryos.
Journal: Cellular reprogramming 20100201
Title: Scriptaid, a novel histone deacetylase inhibitor, enhances the response of human tumor cells to radiation.
Journal: International journal of molecular medicine 20100101
Title: Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.
Journal: Nature chemical biology 20100101
Title: Histone deacetylase inhibitor uses p21(Cip1) to maintain anergy in CD4+ T cells.
Journal: International immunopharmacology 20091001
Title: Significant improvement in cloning efficiency of an inbred miniature pig by histone deacetylase inhibitor treatment after somatic cell nuclear transfer.
Journal: Biology of reproduction 20090901
Title: The histone deacetylase inhibitor scriptaid enhances nascent mRNA production and rescues full-term development in cloned inbred mice.
Journal: Reproduction (Cambridge, England) 20090801
Title: Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages.
Journal: Archives of pharmacal research 20090401
Title: Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells.
Journal: International journal of oncology 20081001
Title: Acetylation of histone H3 and adrenergic-regulated gene transcription in rat pinealocytes.
Journal: Endocrinology 20071001
Title: Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro.
Journal: The Journal of parasitology 20070601
Title: Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
Journal: Circulation 20060606
Title: A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Journal: International journal of molecular medicine 20060201
Title: Fetal hemoglobin induction by the histone deacetylase inhibitor, scriptaid.
Journal: Cellular and molecular biology (Noisy-le-Grand, France) 20050905
Title: Induction of human gamma globin gene expression by histone deacetylase inhibitors.
Journal: Blood 20040115
Title: (2-amino-phenyl)-amides of omega-substituted alkanoic acids as new histone deacetylase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20040105
Title: A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
Journal: Breast cancer research and treatment 20031001
Title: A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.
Journal: Cancer research 20000615
Title: Keen JC, et al. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine. Breast Cancer Res Treat. 2003 Oct;81(3):177-86.
Title: Strobl JS, et al. Scriptaid and suberoylanilide hydroxamic acid are histone deacetylase inhibitors with potent anti-Toxoplasma gondii activity in vitro. J Parasitol. 2007 Jun;93(3):694-700.
Title: Janaki Ramaiah M, et al. Scriptaid cause histone deacetylase inhibition and cell cycle arrest in HeLa cancer cells: A study on structural and functional aspects. Gene. 2017 Sep 5;627:379-386.
Title: Ghosh SK, et al. Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents. Blood. 2012 Jan 26;119(4):1008-17.
